"Technologies may have implications for improving clinical diagnosis and prognosis, and for the development of therapeutic interventions, specific biomarkers, and preventive strategies. Given the amount of existing and ever-growing quantitative assessments using technology in PD, clinicians, patients and researchers are faced with the challenge of deciding which assessment tool to use in the laboratory, clinic ...
"Healthcare professionals and pharmaceutical companies invest a great amount of time and effort in continuously creating electronic health solutions. These technology system developments may represent a step forward in care as ultimately it is not possible to manage what cannot be evaluated. Yet, the use of future generations of technology depends on their specific design, fabrication, distribution, and, most i...
"Objectives: To determine and compare the frequency of undernutrition in institutionalized elderly patients with neurological diseases at admission using different nutritional assessment tools. Design: Cross-sectional observational study. Setting: One long-term care institution specialized in neurodegenerative diseases. Participants: 92 Elderly people (aged ≥ 65 years) with at least one neurological condition. ...
Submitted by Guilherme Lemeszenski (guilherme@nead.unesp.br) on 2013-08-22T18:55:58Z No. of bitstreams: 1 S0102-09352007000400026.pdf: 193153 bytes, checksum: bb43c502149d80c5aed61333b252da8c (MD5); Made available in DSpace on 2013-08-22T18:55:58Z (GMT). No. of bitstreams: 1 S0102-09352007000400026.pdf: 193153 bytes, checksum: bb43c502149d80c5aed61333b252da8c (MD5) Previous issue date: 2007-08-01; Made availabl...
Background: The LRRK2 G2019S mutation is the most frequent known cause of familial and sporadic Parkinson's disease. Knowledge of its worldwide frequency distribution is essential for clinical and molecular research as well as genetic counseling. Objectives: To conduct a systematic review of the reported frequency of G2019S in different populations and to assess critically the quality of the clinical studies. M...